SpendQueryAI-powered · Beta

75A50122D00004↗

Seqirus Inc received this contract vehicle from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $0 obligated so far for drugs and biologicals. It runs to 2027-02-21.

Key facts · data as of Oct 23, 2026

Recipient
Seqirus Inc
Awarding agency
Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
Contracting office
Barda - Aspr / Daappo / Barda Dcma (75A501)
Obligated to date
$0
Potential value
$13.40B
Ends
2027-02-21

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.

Cite this page: SpendQuery, Award 75A50122D00004, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_IDV_75A50122D00004_7505

Seqirus Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief

THE PURPOSE OF THIS REQUIREMENT IS TO 1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED PUBLIC HEALTH EMERGENCY. 2) PRODUCE VACCINES AG

Idc · Office of Assistant Secretary for Preparedness and Response · to Seqirus Inc (UEI Z6N1LJ2RD6E3) · data as of 2026-10-23

Obligated to date$011 actions
Potential value$13.40Bif every option is used
Period2022-02-22 → 2027-02-21current end date

Up for re-bid: ends 2027-02-21. Recompete brief →

What it is

Product or service
Drugs and Biologicals (PSC 6505)
Industry
Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
Contracting office
Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition
Full and open competition · 4 offers received
Pricing
Firm fixed price
How it was bought
Contract vehicle (IDV) itself
Solicitation
75A50121R00013

Obligations by fiscal year

FY2023$0
FY2024$0
FY2025$0
FY2026$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Orders under this vehicle

13 orders worth $133.85M (current value). The largest:

Every action

11 actions since 2022-11-01. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-03-24P00014Administrative change$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-12-12P00013Administrative change$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-11-20P00012Option exercised$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-10-14P00011Administrative change$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-06-12P00010Administrative change$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-05-08P00009Administrative change$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2025-01-21P00008Option exercised$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
2024-03-13P00007Administrative change$0THIS MODIFICATION UPDATES ARTICLE H.3 HHSAR 352.237-75 KEY PERSONNEL- REPLACING PAYAL PATEL, HEAD, PMO AND OPERATIONAL GOVERNANCE WITH MARIA LACOURT-CUEVAS, HEAD, PMO AND OPERATIONAL GOVERNANCE AND CORRECTS THE PERIOD OF PERFORMANCE TO INCLUDE ONLY T
2023-07-06P00006Administrative change$0THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO ADD FAR CLAUSE 52.204-27, PROHIBITION ON A BYTEDANCE COVERED APPLICATION TO ARTICLE I.1. FAR 52.252-2, CLAUSES INCORPORATED BY REFERENCE (FEBRUARY 1998), PARAGRAPH A. FEDERAL ACQUISITION REGULATIO
2023-03-06P00005Administrative change$0THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO UPDATE THE KEY PERSONNEL TO REFLECT RECENT STAFF CHANGES.
2022-11-01P00004Administrative change$0THE PURPOSE OF THIS REQUIREMENT IS TO 1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED PUBLIC HEALTH EMERGENCY. 2) PRODUCE VACCINES AG

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗